CNS Pharmaceuticals Inc (CNSP)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -270.37 | -1749.586 | -90.215 | -79.596 | -114.067 | -140.064 | -255.537 |
| Return on Equity (%) | 742.373 | 2431.579 | -109.955 | -87.781 | -136.471 | -207.035 | -1018.698 |
| Return on Invested Capital (%) | 728.814 | 250.925 | -110.191 | -89.135 | -147.871 | -234.732 | -1211.625 |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | -0.006 | -0.043 | 0.462 | 0.585 | 0.237 | 0.203 | -0.844 |
| Earnings Per Share | -0.021 | -0.582 | -0.236 | -0.396 | -0.503 | -0.382 | -3.591 |
| Cash Per Share | 0.011 | 0.022 | 0.44 | 0.588 | 0.179 | 0.251 | 0.105 |
| Working Capital Per Share | -0.006 | -0.051 | 0.461 | 0.57 | 0.191 | 0.191 | -0.865 |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | -0.021 | -0.582 | -0.236 | -0.396 | -0.503 | -0.382 | -3.591 |
| EBITDA Per Share | -0.021 | -0.582 | -0.236 | -0.396 | -0.503 | -0.382 | -3.591 |
| Free Cash Flow Per Share | -0.021 | -0.582 | -0.235 | -0.396 | -0.503 | -0.382 | -3.591 |
| Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 10.27M | 12.7M | 16.45M | 23.86M | 27.93M | N/A | N/A |
| Year End December 30 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||
| Shares Outstanding | 40.03M | N/A | N/A | 1.62M | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 3.6M |
| Price to Earnings Ratio | -0.17 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 5.85 |
| Price to Book Ratio | -0.73 |
| Dividend Yield | - |
| Shares Outstanding | 32.15M |
| Average Volume (1 week) | 2.58M |
| Average Volume (1 Month) | 9M |
| 52 Week Change | -99.91% |
| 52 Week High | 114.50 |
| 52 Week Low | 0.0955 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
